Literature DB >> 9632808

Targeted disruption of the gene encoding hepatocyte nuclear factor 3gamma results in reduced transcription of hepatocyte-specific genes.

K H Kaestner1, H Hiemisch, G Schütz.   

Abstract

The winged helix transcription factor hepatocyte nuclear factor 3gamma (HNF3gamma) is expressed in embryonic endoderm and its derivatives liver, pancreas, stomach, and intestine, as well as in testis and ovary. We have generated mice carrying an Hnf3g-lacZ fusion which deletes most of the HNF3gamma coding sequence as well as 5.5 kb of 3' flanking region. Mice homozygous for the mutation are fertile, develop normally, and show no morphological defects. The mild phenotype change of the Hnf3g-/- mice can be explained in part by an upregulation of HNF3alpha and HNF3beta in the liver of the mutant animals. Analysis of steady-state mRNA levels as well as transcription rates showed that levels of expression of several HNF3 target genes (phosphoenolpyruvate carboxykinase, transferrin, tyrosine aminotransferase) were reduced by 50 to 70%, indicating that HNF3gamma is an important activator of these genes in vivo.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9632808      PMCID: PMC109008          DOI: 10.1128/MCB.18.7.4245

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  29 in total

Review 1.  Liver-enriched transcription factors and hepatocyte differentiation.

Authors:  S Cereghini
Journal:  FASEB J       Date:  1996-02       Impact factor: 5.191

2.  Method for detection of specific RNAs in agarose gels by transfer to diazobenzyloxymethyl-paper and hybridization with DNA probes.

Authors:  J C Alwine; D J Kemp; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

3.  Universal beta-galactosidase cloning vectors for promoter analysis and gene targeting.

Authors:  K H Kaestner; L Montoliu; H Kern; M Thulke; G Schütz
Journal:  Gene       Date:  1994-10-11       Impact factor: 3.688

4.  Transcriptional regulation in endoderm development: characterization of an enhancer controlling Hnf3g expression by transgenesis and targeted mutagenesis.

Authors:  H Hiemisch; G Schütz; K H Kaestner
Journal:  EMBO J       Date:  1997-07-01       Impact factor: 11.598

5.  The HNF-3 gene family of transcription factors in mice: gene structure, cDNA sequence, and mRNA distribution.

Authors:  K H Kaestner; H Hiemisch; B Luckow; G Schütz
Journal:  Genomics       Date:  1994-04       Impact factor: 5.736

Review 6.  Molecular genetics of early liver development.

Authors:  K S Zaret
Journal:  Annu Rev Physiol       Date:  1996       Impact factor: 19.318

7.  Targeted mutation of the CREB gene: compensation within the CREB/ATF family of transcription factors.

Authors:  E Hummler; T J Cole; J A Blendy; R Ganss; A Aguzzi; W Schmid; F Beermann; G Schütz
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

8.  Transcription factors and aldolase B gene expression in microdissected renal proximal tubules and derived cell lines.

Authors:  V Vallet; M Bens; B Antoine; F Levrat; L Miquerol; A Kahn; A Vandewalle
Journal:  Exp Cell Res       Date:  1995-02       Impact factor: 3.905

9.  Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome.

Authors:  M Pontoglio; J Barra; M Hadchouel; A Doyen; C Kress; J P Bach; C Babinet; M Yaniv
Journal:  Cell       Date:  1996-02-23       Impact factor: 41.582

10.  The winged-helix transcription factor HNF-3 beta is required for notochord development in the mouse embryo.

Authors:  D C Weinstein; A Ruiz i Altaba; W S Chen; P Hoodless; V R Prezioso; T M Jessell; J E Darnell
Journal:  Cell       Date:  1994-08-26       Impact factor: 41.582

View more
  39 in total

1.  Elevated levels of hepatocyte nuclear factor 3beta in mouse hepatocytes influence expression of genes involved in bile acid and glucose homeostasis.

Authors:  F M Rausa; Y Tan; H Zhou; K W Yoo; D B Stolz; S C Watkins; R R Franks; T G Unterman; R H Costa
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

2.  Insulin's expanding control of forkheads.

Authors:  Michael P Czech
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-23       Impact factor: 11.205

3.  Foxa1 and Foxa2 are essential for sexual dimorphism in liver cancer.

Authors:  Zhaoyu Li; Geetu Tuteja; Jonathan Schug; Klaus H Kaestner
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

4.  FoxA family members are crucial regulators of the hypertrophic chondrocyte differentiation program.

Authors:  Andreia Ionescu; Elena Kozhemyakina; Claudia Nicolae; Klaus H Kaestner; Bjorn R Olsen; Andrew B Lassar
Journal:  Dev Cell       Date:  2012-05-15       Impact factor: 12.270

5.  Foxa1 and Foxa2 regulate bile duct development in mice.

Authors:  Zhaoyu Li; Peter White; Geetu Tuteja; Nir Rubins; Sara Sackett; Klaus H Kaestner
Journal:  J Clin Invest       Date:  2009-05-11       Impact factor: 14.808

Review 6.  On the origin of the beta cell.

Authors:  Jennifer M Oliver-Krasinski; Doris A Stoffers
Journal:  Genes Dev       Date:  2008-08-01       Impact factor: 11.361

7.  FOXA2 regulates a network of genes involved in critical functions of human intestinal epithelial cells.

Authors:  Nehal Gosalia; Rui Yang; Jenny L Kerschner; Ann Harris
Journal:  Physiol Genomics       Date:  2015-04-28       Impact factor: 3.107

8.  Overexpression of c-myc in diabetic mice restores altered expression of the transcription factor genes that regulate liver metabolism.

Authors:  Efren Riu; Tura Ferre; Alex Mas; Antonio Hidalgo; Sylvie Franckhauser; Fatima Bosch
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

9.  Limited effects of fasting on hepatitis B virus (HBV) biosynthesis in HBV transgenic mice.

Authors:  Lie Li; Claudia E Oropeza; Klaus H Kaestner; Alan McLachlan
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

10.  Role of Foxa-2 in adipocyte metabolism and differentiation.

Authors:  Christian Wolfrum; David Q Shih; Satoru Kuwajima; Andrew W Norris; C Ronald Kahn; Markus Stoffel
Journal:  J Clin Invest       Date:  2003-07-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.